+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclic Peptide Library Market by Research (Biochemical Research, Drug Discovery, Structural Biology) - Global Forecast 2025-2030- Product Image
Cyclic Peptide Library Market by Research (Biochemical Research, Drug Discovery, Structural Biology) - Global Forecast 2025-2030- Product Image
New

Cyclic Peptide Library Market by Research (Biochemical Research, Drug Discovery, Structural Biology) - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Cyclic peptide libraries represent a unique class of biomolecules characterized by a head-to-tail cyclized backbone that imparts exceptional stability and target specificity. These libraries are assembled through combinatorial synthesis strategies that enable the rapid generation and screening of millions of variant sequences. Their robust performance in binding assays and resistance to proteolytic degradation have made them indispensable tools for uncovering high-affinity ligands in a variety of research settings.

In addition, their applications have steadily expanded beyond classic biochemical screens to include advanced structural biology investigations. Constrained cyclic scaffolds now facilitate crystal formation in X-ray crystallography, while their defined conformations enhance data quality in NMR spectroscopy. As interdisciplinary teams pursue novel therapeutic candidates for oncology, infectious diseases, and cardiovascular disorders, cyclic peptide collections continue to accelerate hit identification and support seamless transitions into lead optimization workflows.

Identifying the Most Impactful Shifts in Cyclic Peptide Library Technology and Market Dynamics That Are Redefining Biopharmaceutical Research Approaches

Over recent years, the landscape has shifted dramatically as advancements in combinatorial chemistry and high-throughput screening technologies have converged. Automation platforms now integrate seamlessly with machine learning algorithms to prioritize candidate sequences based on predicted binding energies and pharmacokinetic profiles. Moreover, the advent of microfluidic screening systems has drastically reduced reagent consumption and expanded the scale at which library members can be evaluated.

Consequently, research organizations are embracing open innovation models that bring together academic groups, specialized service providers, and biotechnology firms. Collaborative networks are co-developing custom cyclic peptide libraries tailored to challenging targets, while shared data repositories accelerate collective learning. This transformative shift is enabling more agile discovery cycles and fostering cross-disciplinary synergies that were previously unattainable.

Assessing the Influence of New United States Tariffs in 2025 on Cyclic Peptide Library Supply Chains Manufacturing Strategies and Global Research Collaborations

The introduction of revised United States tariffs in 2025 has introduced new cost considerations for laboratories relying on imported reagents and custom synthesis services. Increased duties on key amino acid derivatives and specialty resins have led many organizations to reassess their procurement strategies. Some academic institutions have pivoted toward domestic suppliers to mitigate uncertainty, while contract research organizations are renegotiating long-term agreements to absorb or offset additional charges.

This tariff environment has also spurred investments in in-house peptide synthesis capabilities. By expanding internal manufacturing footprints and adopting modular synthesizer technologies, several research groups seek to reduce reliance on international supply chains. At the same time, strategic partnerships between North American firms and overseas producers are emerging to diversify sourcing options and share the burden of fluctuating trade policies.

Revealing Deep Insights into Application Segmentation That Span Drug Discovery Structural Biology Techniques and Therapeutic Use Cases in Cyclic Peptide Libraries

Within biochemical research applications, cyclic peptide libraries continue to support enzymatic assays, receptor binding studies, and interrogations of protein-protein interactions. High-throughput hit identification teams leverage automated synthesis platforms to rapidly screen billions of variants, while downstream lead optimization groups employ iterative design cycles to refine binding affinities and improve pharmacological properties. Simultaneously, structural biology efforts benefit from macrocyclic constraints that yield superior crystal lattice formation in crystallography and enhanced signal resolution in nuclear magnetic resonance studies.

In therapeutic development, cardiovascular researchers apply these libraries against heart failure and hypertension targets to discover novel modulators of receptor signaling. Infectious disease specialists evaluate cyclic macrocycles for activity against bacterial, fungal, and viral proteins, seeking scaffolds that resist enzymatic degradation in vivo. Oncology teams explore both hematological malignancies and solid tumors by integrating library data with phenotypic screening platforms, ultimately guiding the selection of lead candidates with the potential for optimized tumor penetration and reduced off-target effects.

Examining Regional Trends and Drivers Affecting the Adoption of Cyclic Peptide Libraries Across the Americas EMEA and Asia Pacific Markets

In the Americas, robust academic research ecosystems and significant government funding initiatives continue to drive demand for cyclic peptide libraries. Collaborations between universities and biotech firms have accelerated access to advanced screening services, while North American contract research organizations differentiate themselves by providing end-to-end peptide customization and analytical support. This regional dynamic fosters rapid adoption of the latest synthesis and screening innovations alongside established pharmaceutical pipelines.

Europe, the Middle East and Africa have witnessed growing alignment around regulatory frameworks and quality standards for peptide manufacturing. Harmonization of guidelines across the European Union and heightened investments in centralized facilities are streamlining distribution of custom cyclic peptide services. Meanwhile, Asia-Pacific markets are experiencing a surge in biopharmaceutical research hubs that combine academic expertise with cost-effective manufacturing capabilities. Partnerships between regional hubs and global players are expanding local production and reinforcing near-shore sourcing models.

Highlighting Leading Organizations and Strategic Collaborations That Are Driving Innovation and Competition in the Cyclic Peptide Library Market Landscape

Numerous biotechnology innovators and established reagent suppliers have solidified their positions through targeted investments in cyclic peptide platforms and specialized screening technologies. These organizations have enhanced their product portfolios by integrating proprietary chemistries that accelerate library synthesis cycles and improve purity profiles. Strategic alliances with academic consortia and infrastructure providers have further extended their reach into niche research communities.

Leading firms have also pursued collaborations with computational biology ventures to blend in silico modeling with experimental validation workflows. Contract research organizations have become key enablers of this convergence by offering modular service offerings that encompass peptide design, custom synthesis, and high-throughput screening. Collectively, these strategic maneuvers are elevating competitive differentiation and fostering a richer landscape of end-to-end peptide discovery solutions.

Strategic Recommendations to Optimize Research Investments and Foster Competitive Advantage in the Rapidly Evolving Cyclic Peptide Library Sector

Industry leaders should prioritize investment in integrated digital screening infrastructures that marry automated synthesis with machine learning-driven analytics. By building flexible platforms capable of generating and evaluating diverse cyclic peptide scaffolds, research teams can accelerate discovery timelines and reduce iterative bottlenecks. At the same time, cultivating a geographically diversified network of synthesis providers will mitigate exposure to trade policy fluctuations and logistical constraints.

Furthermore, fostering deep collaborations across academic, industrial, and regulatory stakeholders will enable shared learning and standardization of best practices. Engaging with global consortia and participating in pre-competitive research initiatives can accelerate collective progress, while proactive dialogue with regulatory bodies will ensure that novel cyclic peptide modalities meet evolving quality and safety requirements.

Detailing the Comprehensive Research Methodology Employing Qualitative and Quantitative Analyses to Ensure Robust Insights into Cyclic Peptide Libraries

The research framework combined an extensive review of scientific publications, patent filings and open-access data repositories to map current capabilities and emerging innovations in cyclic peptide libraries. Key performance indicators such as synthesis throughput, screening efficiency and structural resolution were identified through comparative analyses of academic and commercial workflows.

Complementing secondary research, in-depth interviews were conducted with thought leaders across universities, contract research organizations and biotechnology companies. Responses were triangulated against quantitative data drawn from peer-reviewed studies and experimental protocols. Iterative peer reviews by independent subject matter experts validated the findings, ensuring the report reflects both established methodologies and nascent technologies poised to reshape the field.

Synthesizing Key Findings and Future Outlook to Guide Stakeholder Decisions and Shape the Trajectory of Cyclic Peptide Library Innovations

The analysis underscores the transformative potential of cyclic peptide libraries as foundational tools in modern biochemical research, structural studies and therapeutic discovery. Technological advances, coupled with shifts in trade policy and regional dynamics, are collectively shaping a more interconnected and resilient ecosystem for peptide discovery.

By synthesizing insights across application areas, tariff impacts and geographic trends, stakeholders are better equipped to navigate complexities and align strategic priorities. Future trajectories will likely center on deeper integration of artificial intelligence, expansion of localized production capabilities and cross-sector partnerships that unite complementary expertise to drive the next wave of peptide-based innovations.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Research
    • Biochemical Research
    • Drug Discovery
      • Hit Identification
      • Lead Optimization
    • Structural Biology
      • Crystallography
      • NMR
    • Therapeutics
      • Cardiovascular
        • Heart Failure
        • Hypertension
      • Infectious Diseases
        • Bacterial
        • Fungal
        • Viral
      • Oncology
        • Hematological Malignancies
        • Solid Tumor
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • PeptiDream Inc.
  • Bicycle Therapeutics Ltd
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca PLC
  • Roche Holding AG
  • Boehringer Ingelheim International GmbH
  • Astellas Pharma Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of high-throughput screening technologies to expand cyclic peptide diversity and accelerate lead identification
5.2. Adoption of advanced computational peptide modeling and AI driven design for optimizing cyclic peptide pharmacokinetics
5.3. Implementation of novel synthesis platforms for rapid and cost effective production of complex cyclic peptide libraries
5.4. Emergence of macrocyclic peptide therapeutics targeting previously undruggable protein-protein interactions in oncology
5.5. Collaborative partnerships between biotech startups and academic centers to enhance cyclic peptide discovery pipelines
5.6. Rising interest in cell penetrating cyclic peptide libraries for intracellular target modulation and delivery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cyclic Peptide Library Market, by Research
8.1. Introduction
8.2. Biochemical Research
8.3. Drug Discovery
8.3.1. Hit Identification
8.3.2. Lead Optimization
8.4. Structural Biology
8.4.1. Crystallography
8.4.2. NMR
8.5. Therapeutics
8.5.1. Cardiovascular
8.5.1.1. Heart Failure
8.5.1.2. Hypertension
8.5.2. Infectious Diseases
8.5.2.1. Bacterial
8.5.2.2. Fungal
8.5.2.3. Viral
8.5.3. Oncology
8.5.3.1. Hematological Malignancies
8.5.3.2. Solid Tumor
9. Americas Cyclic Peptide Library Market
9.1. Introduction
9.2. United States
9.3. Canada
9.4. Mexico
9.5. Brazil
9.6. Argentina
10. Europe, Middle East & Africa Cyclic Peptide Library Market
10.1. Introduction
10.2. United Kingdom
10.3. Germany
10.4. France
10.5. Russia
10.6. Italy
10.7. Spain
10.8. United Arab Emirates
10.9. Saudi Arabia
10.10. South Africa
10.11. Denmark
10.12. Netherlands
10.13. Qatar
10.14. Finland
10.15. Sweden
10.16. Nigeria
10.17. Egypt
10.18. Turkey
10.19. Israel
10.20. Norway
10.21. Poland
10.22. Switzerland
11. Asia-Pacific Cyclic Peptide Library Market
11.1. Introduction
11.2. China
11.3. India
11.4. Japan
11.5. Australia
11.6. South Korea
11.7. Indonesia
11.8. Thailand
11.9. Philippines
11.10. Malaysia
11.11. Singapore
11.12. Vietnam
11.13. Taiwan
12. Competitive Landscape
12.1. Market Share Analysis, 2024
12.2. FPNV Positioning Matrix, 2024
12.3. Competitive Analysis
12.3.1. PeptiDream Inc.
12.3.2. Bicycle Therapeutics Ltd
12.3.3. Merck & Co., Inc.
12.3.4. Pfizer Inc.
12.3.5. Novartis AG
12.3.6. Amgen Inc.
12.3.7. AstraZeneca PLC
12.3.8. Roche Holding AG
12.3.9. Boehringer Ingelheim International GmbH
12.3.10. Astellas Pharma Inc.
13. ResearchAI
14. ResearchStatistics
15. ResearchContacts
16. ResearchArticles
17. Appendix
List of Figures
FIGURE 1. CYCLIC PEPTIDE LIBRARY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 8. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 10. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. ASIA-PACIFIC CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. ASIA-PACIFIC CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. CYCLIC PEPTIDE LIBRARY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 16. CYCLIC PEPTIDE LIBRARY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 17. CYCLIC PEPTIDE LIBRARY MARKET: RESEARCHAI
FIGURE 18. CYCLIC PEPTIDE LIBRARY MARKET: RESEARCHSTATISTICS
FIGURE 19. CYCLIC PEPTIDE LIBRARY MARKET: RESEARCHCONTACTS
FIGURE 20. CYCLIC PEPTIDE LIBRARY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYCLIC PEPTIDE LIBRARY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY BIOCHEMICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY BIOCHEMICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HIT IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CRYSTALLOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CRYSTALLOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY NMR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY NMR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY FUNGAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 92. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 93. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 94. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 95. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 96. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 97. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 98. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 99. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 100. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 101. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 102. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 103. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 104. CANADA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 105. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 106. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 107. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 108. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 109. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 114. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 177. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 178. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 179. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 180. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 181. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 182. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 183. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 184. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 185. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 186. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 187. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 188. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 189. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 190. GERMANY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 191. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 192. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 193. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 194. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 195. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 196. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 197. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 200. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 201. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 202. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 203. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 204. FRANCE CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 219. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 220. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 221. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 222. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 223. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 224. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 225. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 226. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 227. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 228. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 229. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 230. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 231. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. ITALY CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 234. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 235. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 236. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 237. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 238. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 239. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 242. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 243. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 244. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 245. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 246. SPAIN CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 289. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 290. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 291. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 292. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 293. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 294. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 295. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 298. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 299. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 300. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 301. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 302. DENMARK CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 317. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 318. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 319. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 320. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 321. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 322. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY STRUCTURAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 323. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 324. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 325. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 326. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 327. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 328. QATAR CYCLIC PEPTIDE LIBRARY MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cyclic Peptide Library market report include:
  • PeptiDream Inc.
  • Bicycle Therapeutics Ltd
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca PLC
  • Roche Holding AG
  • Boehringer Ingelheim International GmbH
  • Astellas Pharma Inc.

Related Reports

Plant-derived Cyclic Peptide Market by Product Type (Cyclic Dipeptides, Cyclotides, Lipopeptides), Application (Anticancer, Antimicrobial, Antiviral), End User, Route of Administration, Manufacturing Process, Molecular Weight - Global Forecast 2025-2030 - Product Image

Plant-derived Cyclic Peptide Market by Product Type (Cyclic Dipeptides, Cyclotides, Lipopeptides), Application (Anticancer, Antimicrobial, Antiviral), End User, Route of Administration, Manufacturing Process, Molecular Weight - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Cyclic Peptides Market by Type (Natural Cyclic Peptide, Synthetic Cyclic Peptide), Product (Antimicrobial Peptides, Hormonal Peptides, Immunomodulating Peptides), Technology, Application, End User - Global Forecast 2025-2030 - Product Image

Cyclic Peptides Market by Type (Natural Cyclic Peptide, Synthetic Cyclic Peptide), Product (Antimicrobial Peptides, Hormonal Peptides, Immunomodulating Peptides), Technology, Application, End User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
AI-driven Peptide Drug Discovery Platform Market by Technology Type, Therapeutic Application, End User, Peptide Class, Workflow Stage - Global Forecast 2025-2030 - Product Image

AI-driven Peptide Drug Discovery Platform Market by Technology Type, Therapeutic Application, End User, Peptide Class, Workflow Stage - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Synthetic Methodology Related to Peptide and Proteins - Product Image

Synthetic Methodology Related to Peptide and Proteins

  • Book
Cosmetic Cyclic Peptide Raw Materials Market by Application (Anti-Aging, Hair Growth, Moisturization), Peptide Type (Disulfide Bonded, Head to Tail Cyclization, Side Chain Cyclization), End User, Grade, Form, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cosmetic Cyclic Peptide Raw Materials Market by Application (Anti-Aging, Hair Growth, Moisturization), Peptide Type (Disulfide Bonded, Head to Tail Cyclization, Side Chain Cyclization), End User, Grade, Form, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.